Impaired metabolic response to recombinant insulin-like growth factor-1 in dialysis patients
- 1 March 1995
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 47 (3) , 876-883
- https://doi.org/10.1038/ki.1995.131
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Effects of insulin-like growth factor I on renal function in normal menKidney International, 1993
- Insulin Secretory Profiles and C-Peptide Clearance Kinetics at 6 Months and 2 Years After Kidney-Pancreas TransplantationDiabetes, 1992
- Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemiaPediatric Nephrology, 1991
- Nutritional Assessment of Continuous Ambulatory Peritoneal Dialysis Patients: An International StudyAmerican Journal of Kidney Diseases, 1991
- The Endocrine Role of Insulin‐Like Growth Factor IActa Paediatrica, 1991
- IGF Binding Proteins in Growth-Retarded Children with Chronic Renal FailurePediatric Research, 1989
- Serum Concentrations of Insulin-Like Growth Factor (IGF)-1, IGF-2 and Unsaturated Somatomedin Carrier Proteins in Children With Chronic Renal FailureAmerican Journal of Kidney Diseases, 1987
- New standards of weight and body composition by frame size and height for assessment of nutritional status of adults and the elderlyThe American Journal of Clinical Nutrition, 1984
- Circulating somatomedin activity and sulfate levels in adults with normal and impaired kidney functionMetabolism, 1981
- SOMATOMEDIN ACTIVITY AND INORGANIC SULFATE IN CHILDREN UNDERGOING HEMODIALYSISJournal of Clinical Endocrinology & Metabolism, 1978